Washington Roundup, February 2013
Executive Summary
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence’s “The Gray Sheet.”
You may also be interested in...
Entellus Launches New Sinus Treatment Device; Prepares To Release Data From Randomized Study
While launching a new balloon-based device to treat chronic sinusitis, Entellus Medical Inc. revealed it would release details on an important clinical study in July.
FDA To Issue Final Device Post-Market Surveillance Plan In February
The device center plans to publish the final version of its national device post-market surveillance strategy and select a third-party group to run its MDEpiNet public-private partnership by the end of February.
Illumina Stakes A Claim In NIPT Market With $450-Million Acquisition Of Verinata
Gene-sequencing company Illumina has signed a definitive agreement to acquire Verinata Health for up to $450 million, staking its claim in the fast-growing, noninvasive prenatal genetic-testing market.